WallStSmart
MNMD

Mind Medicine Inc

NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY

$15.02
+1.01% today

Updated 2026-01-14

Market cap
$1.46B
P/E ratio
P/S ratio
EPS (TTM)
$-1.98
Dividend yield
52W range
$5 – $15
Volume
1.9M

WallStSmart proprietary scores

20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →195 stocks currently score above 75

Price targets

Analyst target
$28.67
+90.88%
12-Month target
Intrinsic (DCF)
Margin of safety
3 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-29.57M

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-93.04M$-56.80M$-95.73M$-108.68M$-67.27M
EPS$-1.98
Free cash flow$-45.82M$-50.14M$-64.36M$-79.13M$-29.57M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
MNMD$1.46B204.33.05.05.0Avoid
LLY$869.41B7810.010.05.06.5Strong Buy
JNJ$535.63B594.79.03.36.0-38.45%Buy
ABBV$358.55B634.08.04.05.0-20.52%Buy
UNH$335.78B545.35.57.34.8+42.20%Buy
AZN$286.68B626.08.55.35.0+6.60%Buy

Smart narrative

Mind Medicine Inc trades at $15.02. Our Smart Value Score of 20/100 indicates the stock is weak.

Frequently asked questions

What is Mind Medicine Inc's stock price?
Mind Medicine Inc (MNMD) trades at $15.02.
Is Mind Medicine Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Mind Medicine Inc (MNMD)?
The analyst target price is $28.67, representing +90.9% upside from the current price of $15.02.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-0.86%
Beta2.62
50D MA$13.48
200D MA$10.29
Shares out0.10B
Float0.10B
Short ratio
Avg volume1.9M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years